Zepbound and alcohol: what the label and NIH say

Can you drink alcohol on Zepbound?

The Zepbound label neither allows nor forbids alcohol: it never discusses drinking, and the word appears only as an ingredient and on the alcohol swab.^[1] The Mounjaro label is the same, and so is the label of Lilly's pill Foundayo.^[2][3]

The single-dose pens and vials contain no preservative, so no benzyl alcohol.^[1] The presentations are compared on Zepbound pen vs vial.

Tirzepatide and alcohol: what is known and what is not

For tirzepatide and alcohol, the published record holds label warnings and NIH guidance on each one separately, but no measured result for the combination.^[1][8][7]

Pancreatitis: where Zepbound and alcohol overlap

Pancreatitis is the main overlap: it is a Zepbound label warning, and the NIH names heavy alcohol use as one of the most common causes.^[1][4]

• The label: acute pancreatitis, “including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed.” If it is suspected, Zepbound is stopped.^[1]
• The trials: confirmed pancreatitis was rare and equal on both arms, 0.2% on tirzepatide and 0.2% on placebo.^[1]
• The NIH on causes: the most common causes of pancreatitis are gallstones, heavy alcohol use, genetic disorders and some medicines; “The most common cause of acute pancreatitis is having gallstones.”^[4]
• NIAAA: “Alcohol misuse over time can lead to pancreatitis.”^[5]
• Gallstones link: the Zepbound label also warns of gallbladder disease, with gallstones in 1.1% of people versus 1% on placebo.^[1]

The Medication Guide's warning sign is severe stomach pain that will not go away, with or without vomiting, which may spread to the back.^[1] All the label's warnings are on Zepbound side effects.

Mounjaro and alcohol: low blood sugar

For people taking Mounjaro for diabetes, alcohol adds to the low-blood-sugar risk that tirzepatide carries mainly when combined with insulin or a sulfonylurea.^[1][6] In the Zepbound trial in type 2 diabetes, blood sugar below 54 mg/dL occurred in 4.2% on tirzepatide versus 1.3% on placebo, and in 10.3% of those also on a sulfonylurea.^[1]

• The NIDDK lists “Drinking too much alcohol without enough food” as a cause of low blood sugar.^[6]
• It adds that alcohol “makes it harder for your body to keep your blood glucose level steady,” and can hide the first symptoms of low blood sugar.^[6]
• The NIAAA says that in people with diabetes, “any alcohol intake may reduce their ability to control blood glucose levels adequately.”^[5]

Mounjaro's label carries the same advice to consider lowering insulin or sulfonylurea doses.^[2] More on tirzepatide side effects.

Do you absorb alcohol differently on Zepbound?

That has not been measured: the label says Zepbound slows stomach emptying, but it never tested alcohol, and the one registered study of GLP-1 drugs and alcohol absorption had not started recruiting by November 2026.^[1][7]

• The label: “Tirzepatide delays gastric emptying.” The effect “was greatest after a single dose of 5 mg and diminished after subsequent doses.”^[1]
• Why it matters for pills: the label says the delay “has the potential to impact the absorption of concomitantly administered oral medications,” which is the reason for its birth control pill advice.^[1] It does not extend that statement to alcohol.
• The open study: NCT07758231, a 5-person phase 1 study, is registered to measure how GLP-1 drug therapy affects alcohol levels in the blood.^[7]

Is there a safer day of the week to drink?

No day of a weekly Zepbound schedule is free of the drug: with a half-life of about 5 days, roughly 40% of a dose is still present when the next one is due.^[1]

Each cell is 0.5 raised to the power of days ÷ 5. Because each dose overlaps the next, levels stay fairly steady once 4 weekly doses have been taken.^[1] Timing a drink around the injection day therefore has no basis in the label. The day-by-day curve is on tirzepatide half-life.

Fluid loss from stomach side effects

Zepbound's own stomach side effects can cause fluid loss: diarrhea affected 19–23% and vomiting 8–13% of people on 5–15 mg, and the label links dehydration from them to acute kidney injury.^[1] The Medication Guide asks people to drink fluids and to report vomiting or diarrhea that does not stop.^[1] Most of these effects came in the weeks after a dose increase; see the tirzepatide dosage chart for when the steps fall.^[1]

Does Zepbound reduce alcohol cravings?

That has not been shown in a randomized trial: as of November 2026 the human evidence is observational, and none of the seven registered trials has posted results.^[8][7] Zepbound is approved for weight reduction and sleep apnea, not for alcohol use disorder.^[1]

A PubMed search for tirzepatide and alcohol finds 41 records, none reporting a randomized trial result.^[8] One example is a 2023 remote study of 153 people with obesity who drank alcohol, in which those taking semaglutide or tirzepatide reported lower drinking than a comparison group; it was not randomized.^[9]

Points to raise with a prescriber

Four situations make the alcohol question more important, based on the warnings above.^[1][4][6]

• A past episode of pancreatitis or gallstones.
• Taking insulin or a sulfonylurea for diabetes.
• Regular heavy drinking or alcohol use disorder.
• Ongoing vomiting or diarrhea, especially after a dose increase.

Related

• Zepbound side effectsLabel rates by dose and warning signs
• How long side effects lastWeek-by-week timeline
• Tirzepatide half-lifeHow long the drug stays in the body